Lorbrena tablets 25mg, containing Lorlatinib, is manufactured by Pfizer. This medication (YJ code: 4291055F1020, standard: 25mg 1 tablet) is used to treat adults with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC).
Lorbrena tablets 25mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →